Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company [Yahoo! Finance]
Dyadic International, Inc. (DYAI)
NASDAQ:AMEX Investor Relations:
dyadic.com
Company Research
Source: Yahoo! Finance
biotechnology company announced it has signed a fully funded evaluation agreement including commercial option with an undisclosed leading global biopharmaceutical company to design and produce recombinant proteins using Dyadic's C1 filamentous fungal based microbial protein production platform. Under the agreement, research and development activities will be funded by the collaborator. “Dyadic's C1 protein expression platform is gaining increased traction in research and development targeting infectious and other diseases,” said CEO Mark Emalfarb, "We are glad to see the progress of our C1-cell protein production platform for human and animal biopharmaceuticals and we believe the recent positive Phase I first in human data for a recombinant vaccine produced using C1 will spark further interest in the adoption of Dyadic's C1 technology.” Dyadic is committed to enabling its partners and collaborators in the development of effective preventative and therapeutic treatments globally. D
Show less
Read more
Impact Snapshot
Event Time:
DYAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DYAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DYAI alerts
High impacting Dyadic International, Inc. news events
Weekly update
A roundup of the hottest topics
DYAI
News
- Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024GlobeNewswire
- DYAI: Capital Raise to Accelerate Near Term Revenue Growth [Yahoo! Finance]Yahoo! Finance
- Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Dyadic Reports 2023 Full Year Results and Recent Company Progress [Yahoo! Finance]Yahoo! Finance
- Dyadic Reports 2023 Full Year Results and Recent Company ProgressGlobeNewswire
DYAI
Earnings
- 11/8/23 - In-Line
DYAI
Sec Filings
- 4/24/24 - Form S-3
- 4/24/24 - Form DEFA14A
- 4/24/24 - Form ARS
- DYAI's page on the SEC website